Insider Shareholders with Direct Ownership of Acumen Pharmaceuticals, Inc. (ABOS)
This section provides a comprehensive overview of the insiders with direct ownership of Acumen Pharmaceuticals, Inc. (ABOS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Acumen Pharmaceuticals, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Sands Capital Ventures Discovery Fund Iii, L.P.
> 10% Shareholder |
3,417,075 | 0 | 3,417,075 $8.47 Million | 1 |
Jul 06, 2021
Added 11.64%
|
Daniel Joseph O Connell
President and CEO |
516,276 | 15,210 | 502,485 $1.25 Million | 6 |
Jan 19, 2024
Reduced 2.94%
|
Matt Zuga
CFO & Chief Business Officer |
215,687 | 4,242 | 211,445 $524,383 | 5 |
Jan 18, 2024
Reduced 1.97%
|
John A Stalfort Iii
Director |
165,180 | 0 | 172,324 $427,363 | 1 |
Jul 06, 2021
Added 16.88%
|
Eric Siemers
Chief Medical Officer |
120,700 | 3,124 | 117,576 $291,588 | 3 |
Jan 18, 2024
Reduced 2.59%
|
Derek M Meisner
Chief Legal Officer & Corp Sec |
117,800 | 8,933 | 108,867 $269,990 | 3 |
Jan 19, 2024
Reduced 7.58%
|
Russell Barton
Chief Operating Officer |
99,700 | 2,833 | 96,867 $240,230 | 3 |
Jan 18, 2024
Reduced 2.84%
|
Nathan B Fountain
Director |
6,250 | 0 | 6,250 $15,500 | 1 |
Jul 06, 2021
Added 50.0%
|
Jeffrey L. Ives
Director |
41,949 | 41,949 | 0 $0 | 2 |
Aug 17, 2023
Reduced 100.0%
|